SNDL Inc. has reported its financial results for the three months ended March 31, 2025. The company experienced a net loss of CAD 14.7 million, a significant increase from the CAD 4.7 million net loss reported in the same period in 2024. The company's income tax recovery was not recorded, compared to CAD 3.0 million in the previous year. Interest and fee income decreased to CAD 2.9 million from CAD 4.1 million. There was a change in the fair value of biological assets, which was CAD 1.1 million, compared to CAD 0.2 million in the previous year. Share-based compensation was CAD 1.4 million, down from CAD 4.8 million in 2024. Additionally, SNDL Inc. has eliminated CAD 12.0 million from cannabis operations sales and costs related to transactions with provincial boards, reflecting their plan to repurchase and resell through their licensed retail subsidiaries. The company is also monitoring the potential impacts of tariffs and foreign exchange rate volatility on its financial position, particularly concerning its U.S. sourced inputs.